Colin Hill - 17 Jun 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Curt Oltmans as attorney-in-fact for Colin Hill
Issuer symbol
FULC
Transactions as of
17 Jun 2024
Transactions value $
$0
Form type
4
Filing time
18 Jun 2024, 16:15:04 UTC
Previous filing
08 Dec 2021
Next filing
30 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +60K $0.00 60K 17 Jun 2024 Common Stock 60K $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 17, 2024 and is scheduled to vest in equal monthly installments until June 17, 2027, subject to continued service.